On April 1, 2006, Talecris Biotherapeutics Limited inherited the 20-year legacy established in Canada by our predecessor, Bayer Biological Products. As the primary, chosen supplier of the Canadian blood system, Talecris is committed to continuing to deliver the premier products and services that our Canadian patient communities have trusted for years, and to maintaining and growing our valued relationships with our partners...
Read More |
 |
|
|
| |
